# A Study of 123I-CMICE-013 Radiopharmaceutical in Healthy Volunteers

> **NCT01558362** · PHASE1 · COMPLETED · sponsor: **Ottawa Heart Institute Research Corporation** · enrollment: 12 (actual)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DRUG:** 123I-CMICE-013

## Key facts

- **NCT ID:** NCT01558362
- **Lead sponsor:** Ottawa Heart Institute Research Corporation
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-04
- **Primary completion:** 2012-09
- **Final completion:** 2012-09
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2025-03-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01558362

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01558362, "A Study of 123I-CMICE-013 Radiopharmaceutical in Healthy Volunteers". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01558362. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*